You are here: Industry Insights > patent

News List

Hikma enters into settlement agreement with Jazz for sodium oxybate cphi-online
April 10, 2017
Agreement terms are "favourable for both parties".
A patent analytics study of the Australian pharmaceutical industry pharmafile
March 27, 2017
This report provides an analysis of the Australian pharmaceutical and biopharmaceutical industry through the lens of patents.
US patent office upholds Biogen's patent for Tecfidera firstwordpharma
March 22, 2017
The US Patent and Trademarks Office's Patent Trial and Appeal Board on Tuesday upheld the validity of a patent protecting Biogen's multiple sclerosis treatment Tecfidera (dimethyl fumarate)‎ following a challenge by hedge fund manager Kyle Bass.
Top 10 U.S. patent losses of 2017 fiercepharma
February 27, 2017
Among the many meds that’ll lose patent protection in the U.S. this year are 10 drugs that each contribute in a big way for top drugmakers. Eli Lilly, Pfizer, Takeda, Bristol-Myers Squibb and Gilead are each set to hit the patent cliff this year with some
US patent office rules in favour of Broad Institute over patent rights for gene-editing technology firstwordpharma
February 16, 2017
The US Patent and Trademark Office (USPTO) on Wednesday ruled in favour of the Broad Institute regarding certain CRISPR-Cas9 patents, in a dispute brought by the University of California, which challenged those patents.
EPO upholds decision regarding Sprycel cphi-online
February 06, 2017
Bristol-Myers Squibb Company (BMS) has announced that the European Patent Office (EPO) upheld a decision with regard to European Patent No. 1169038, the active ingredient in Sprycel. The EPO upheld a decision that found the patent to be invalid.
The Medicines Patent Pool Announces First Licence for Tuberculosis Treatment firstwordpharma
January 26, 2017
In an effort to improvetheinternational response to combatting multidrug-resistant TB, MPP andJohns Hopkins University signlicensing agreement forinvestigational treatmentsutezolid
A-SKIN Secures Patent for Groundbreaking Skin Engineering Therapy with Wound Healing Formulation® (W b3cnewswire
January 16, 2017
A-SKIN seeks financing or business deal on preclinical studies with WHF and Tiscover (clinical phase II) .
RedHill Biopharma announces allowance of a patent in Japan supporting RHB-104 for multiple sclerosis pharmaasia
January 13, 2017
RedHill has received from the Japan Patent Office a Notice of Allowance for a new patent covering RHB-104 for multiple sclerosis (MS), expected to be valid until 2032, once granted.
U.S. Court of Appeals Rules In Lilly's Favor On Alimta Vitamin Regimen Patent cphi-online
January 13, 2017
Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Court of Appeals for the Federal Circuit has upheld the district court's decision and ruled in the company's favor regarding validity and infringement of the vitamin regimen patent for Alimta

Previous page 1 2 3 4 5 6 Next page